Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

434 Views

H4. HIV: Treatment

Poster Session: HIV: Treatment

(P-558) Long-acting Injectable Cabotegravir/Rilpivirine Plus Subcutaneous Lenacapavir Effective in People with HIV with Viremia and Cabotegravir or Rilpivirine Resistance-Associated Mutations

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

James B. Brock, MD, MSCI, FACP, FIDSA

Associate Professor of Medicine
University of Mississippi Medical Center
Jackson, Mississippi, United States

Co-Author(s)

RD

Racolesha Denson, NP

University of Mississippi Medical Center
Jackson, Mississippi, United States
PH

Peyton Herrington, PharmD

University of Mississippi Medical Center
Jackson, Mississippi, United States
MH

Melissa Hickman, RN

University of Mississippi Medical Center
Jackson, Mississippi, United States
HK

Heather King, NP

University of Mississippi Medical Center
Jackson, Mississippi, United States
RM

Regan McIntosh, PharmD

University of Mississippi Medical Center
Jackson, Mississippi, United States
SM

Sirna Musa, NP

University of Mississippi Medical Center
Jackson, Mississippi, United States
CS

Courtney Sanders, NP

University of Mississippi Medical Center
Jackson, Mississippi, United States
HW

Holly Walker, NP

University of Mississippi Medical Center
Jackson, Mississippi, United States
AH

Aubri Hickman, PhD, DNP

University of Mississippi Medical Center
Jackson, Mississippi, United States